These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Clinical pharmacokinetics of sulphasalazine. Das KM; Dubin R Clin Pharmacokinet; 1976; 1(6):406-25. PubMed ID: 15752 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of leucocyte motility by drugs used in ulcerative colitis. Rhodes JM; Bartholomew TC; Jewell DP Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649 [TBL] [Abstract][Full Text] [Related]
29. Oral mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858 [No Abstract] [Full Text] [Related]
30. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group. Rutgeerts P Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483 [TBL] [Abstract][Full Text] [Related]
31. Sulphasalazine in ulcerative colitis: in memoriam? Hayllar J; Bjarnason I Gut; 1991 May; 32(5):462-3. PubMed ID: 1674925 [No Abstract] [Full Text] [Related]
33. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis. Cowan GO; Das KM; Eastwood MA Br Med J; 1977 Oct; 2(6094):1057-9. PubMed ID: 21720 [TBL] [Abstract][Full Text] [Related]
34. Role of the intestinal flora in the acetylation of sulfasalazine metabolites. Dull BJ; Salata K; Goldman P Biochem Pharmacol; 1987 Nov; 36(21):3772-4. PubMed ID: 2890356 [No Abstract] [Full Text] [Related]
35. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults. Kam L; Cohen H; Dooley C; Rubin P; Orchard J Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990 [TBL] [Abstract][Full Text] [Related]
36. Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis. Pounder RE; Craven ER; Henthorn JS; Bannatyne JM Gut; 1975 Mar; 16(3):181-5. PubMed ID: 235486 [TBL] [Abstract][Full Text] [Related]
37. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage]. Bresci G; Carrai M; Venturini G; Gambardella L Minerva Dietol Gastroenterol; 1990; 36(1):31-3. PubMed ID: 1970855 [TBL] [Abstract][Full Text] [Related]
38. [Salazosulfapyridine or 5-aminosalicylic acid]. van Hees PA Ned Tijdschr Geneeskd; 1987 May; 131(22):931-4. PubMed ID: 2885762 [No Abstract] [Full Text] [Related]
39. Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. Chan RP; Pope DJ; Gilbert AP; Sacra PJ; Baron JH; Lennard-Jones JE Dig Dis Sci; 1983 Jul; 28(7):609-15. PubMed ID: 6345112 [TBL] [Abstract][Full Text] [Related]
40. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Andreoli A; Spinella S; Levenstein S; Prantera C Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]